Early Diagnosis of Cerebral Ischemia Reperfusion Injury and Revelation of Its Regional Development by a H3R Receptor-Directed Probe.
Junda WangYuanjun ZhuLingfei YangHui LiuTongliang ZhouFengrong XuPing XuLan YuanLei LiangPublished in: ACS sensors (2021)
In vivo imaging of cerebral hydrogen peroxide (H2O2) may facilitate early diagnosis of cerebral ischemia reperfusion injury (CIRI) and a revelation of its pathological progression. In this study, we report our rational design of a brain-targeting fluorescent probe using the basis of a pyridazinone scaffold. A structure-activity relationship study reveals that PCAB is the best candidate (Ki = 15.8 nM) for a histamine H3 receptor (H3R), which is highly expressed in neurons of the central nervous system. As a two-photon fluorescent probe, PCAB exhibits a fast, selective reaction toward both extra- and intracellular H2O2 in SH-SY5Y cells under oxygen glucose deprivation and resupply. In vivo fluorescent imaging of a middle cerebral artery occlusion mouse confirms that PCAB is an ultrasensitive probe with potent blood-brain barrier penetration, precise brain targeting, and fast detection of CIRI.
Keyphrases
- living cells
- fluorescent probe
- blood brain barrier
- ischemia reperfusion injury
- hydrogen peroxide
- cerebral ischemia
- middle cerebral artery
- subarachnoid hemorrhage
- quantum dots
- high resolution
- single molecule
- oxidative stress
- nitric oxide
- induced apoptosis
- structure activity relationship
- resting state
- gold nanoparticles
- internal carotid artery
- photodynamic therapy
- squamous cell carcinoma
- cerebrospinal fluid
- functional connectivity
- cancer therapy
- blood glucose
- neoadjuvant chemotherapy
- multiple sclerosis
- mass spectrometry
- anti inflammatory
- cell cycle arrest